Cargando…

Associations between continuous glucose monitoring-derived metrics and diabetic retinopathy and albuminuria in patients with type 2 diabetes

INTRODUCTION: Preventing the development and progression of diabetic microvascular complications through optimal blood glucose control remains an important challenge. Whether metrics based on continuous glucose monitoring are useful for the management of diabetic microvascular complications is not e...

Descripción completa

Detalles Bibliográficos
Autores principales: Wakasugi, Satomi, Mita, Tomoya, Katakami, Naoto, Okada, Yosuke, Yoshii, Hidenori, Osonoi, Takeshi, Nishida, Keiko, Shiraiwa, Toshihiko, Torimoto, Keiichi, Kurozumi, Akira, Gosho, Masahiko, Shimomura, Iichiro, Watada, Hirotaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061826/
https://www.ncbi.nlm.nih.gov/pubmed/33879513
http://dx.doi.org/10.1136/bmjdrc-2020-001923
_version_ 1783681641163522048
author Wakasugi, Satomi
Mita, Tomoya
Katakami, Naoto
Okada, Yosuke
Yoshii, Hidenori
Osonoi, Takeshi
Nishida, Keiko
Shiraiwa, Toshihiko
Torimoto, Keiichi
Kurozumi, Akira
Gosho, Masahiko
Shimomura, Iichiro
Watada, Hirotaka
author_facet Wakasugi, Satomi
Mita, Tomoya
Katakami, Naoto
Okada, Yosuke
Yoshii, Hidenori
Osonoi, Takeshi
Nishida, Keiko
Shiraiwa, Toshihiko
Torimoto, Keiichi
Kurozumi, Akira
Gosho, Masahiko
Shimomura, Iichiro
Watada, Hirotaka
author_sort Wakasugi, Satomi
collection PubMed
description INTRODUCTION: Preventing the development and progression of diabetic microvascular complications through optimal blood glucose control remains an important challenge. Whether metrics based on continuous glucose monitoring are useful for the management of diabetic microvascular complications is not entirely clear. RESEARCH DESIGN AND METHODS: This is an exploratory analysis of an ongoing prospective, multicenter, 5-year follow-up observational study. Study participants included 999 outpatients with type 2 diabetes who underwent continuous glucose monitoring at baseline. Associations between continuous glucose monitoring-derived metrics and the severity of diabetic retinopathy or albuminuria were investigated using multivariable proportional odds models. RESULTS: The overall prevalence of diabetic retinopathy was 22.2%. Multivariate analysis with proportional odds models demonstrated that continuous glucose monitoring-derived metrics related to intraday and interday glucose variability are significantly associated with the severity of diabetic retinopathy, even after adjusting for various possible risk factors. However, significant relationships were not observed after adjusting for hemoglobin A1c (HbA1c) levels. The prevalence of microalbuminuria and macroalbuminuria was 20.3% and 6.7%, respectively. Similarly, multivariate analysis demonstrated that those metrics are significantly associated with the severity of albuminuria. These relationships remained significant even after further adjusting for HbA1c levels. CONCLUSIONS: Continuous glucose monitoring-derived metrics related to intraday and interday glucose variability are significantly associated with the severity of diabetic retinopathy or albuminuria in patients with type 2 diabetes. Thus, evaluating these metrics might possibly be useful for risk assessment of diabetic microvascular complications. Trial registration number UMIN000032325.
format Online
Article
Text
id pubmed-8061826
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-80618262021-05-11 Associations between continuous glucose monitoring-derived metrics and diabetic retinopathy and albuminuria in patients with type 2 diabetes Wakasugi, Satomi Mita, Tomoya Katakami, Naoto Okada, Yosuke Yoshii, Hidenori Osonoi, Takeshi Nishida, Keiko Shiraiwa, Toshihiko Torimoto, Keiichi Kurozumi, Akira Gosho, Masahiko Shimomura, Iichiro Watada, Hirotaka BMJ Open Diabetes Res Care Pathophysiology/Complications INTRODUCTION: Preventing the development and progression of diabetic microvascular complications through optimal blood glucose control remains an important challenge. Whether metrics based on continuous glucose monitoring are useful for the management of diabetic microvascular complications is not entirely clear. RESEARCH DESIGN AND METHODS: This is an exploratory analysis of an ongoing prospective, multicenter, 5-year follow-up observational study. Study participants included 999 outpatients with type 2 diabetes who underwent continuous glucose monitoring at baseline. Associations between continuous glucose monitoring-derived metrics and the severity of diabetic retinopathy or albuminuria were investigated using multivariable proportional odds models. RESULTS: The overall prevalence of diabetic retinopathy was 22.2%. Multivariate analysis with proportional odds models demonstrated that continuous glucose monitoring-derived metrics related to intraday and interday glucose variability are significantly associated with the severity of diabetic retinopathy, even after adjusting for various possible risk factors. However, significant relationships were not observed after adjusting for hemoglobin A1c (HbA1c) levels. The prevalence of microalbuminuria and macroalbuminuria was 20.3% and 6.7%, respectively. Similarly, multivariate analysis demonstrated that those metrics are significantly associated with the severity of albuminuria. These relationships remained significant even after further adjusting for HbA1c levels. CONCLUSIONS: Continuous glucose monitoring-derived metrics related to intraday and interday glucose variability are significantly associated with the severity of diabetic retinopathy or albuminuria in patients with type 2 diabetes. Thus, evaluating these metrics might possibly be useful for risk assessment of diabetic microvascular complications. Trial registration number UMIN000032325. BMJ Publishing Group 2021-04-20 /pmc/articles/PMC8061826/ /pubmed/33879513 http://dx.doi.org/10.1136/bmjdrc-2020-001923 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Pathophysiology/Complications
Wakasugi, Satomi
Mita, Tomoya
Katakami, Naoto
Okada, Yosuke
Yoshii, Hidenori
Osonoi, Takeshi
Nishida, Keiko
Shiraiwa, Toshihiko
Torimoto, Keiichi
Kurozumi, Akira
Gosho, Masahiko
Shimomura, Iichiro
Watada, Hirotaka
Associations between continuous glucose monitoring-derived metrics and diabetic retinopathy and albuminuria in patients with type 2 diabetes
title Associations between continuous glucose monitoring-derived metrics and diabetic retinopathy and albuminuria in patients with type 2 diabetes
title_full Associations between continuous glucose monitoring-derived metrics and diabetic retinopathy and albuminuria in patients with type 2 diabetes
title_fullStr Associations between continuous glucose monitoring-derived metrics and diabetic retinopathy and albuminuria in patients with type 2 diabetes
title_full_unstemmed Associations between continuous glucose monitoring-derived metrics and diabetic retinopathy and albuminuria in patients with type 2 diabetes
title_short Associations between continuous glucose monitoring-derived metrics and diabetic retinopathy and albuminuria in patients with type 2 diabetes
title_sort associations between continuous glucose monitoring-derived metrics and diabetic retinopathy and albuminuria in patients with type 2 diabetes
topic Pathophysiology/Complications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061826/
https://www.ncbi.nlm.nih.gov/pubmed/33879513
http://dx.doi.org/10.1136/bmjdrc-2020-001923
work_keys_str_mv AT wakasugisatomi associationsbetweencontinuousglucosemonitoringderivedmetricsanddiabeticretinopathyandalbuminuriainpatientswithtype2diabetes
AT mitatomoya associationsbetweencontinuousglucosemonitoringderivedmetricsanddiabeticretinopathyandalbuminuriainpatientswithtype2diabetes
AT katakaminaoto associationsbetweencontinuousglucosemonitoringderivedmetricsanddiabeticretinopathyandalbuminuriainpatientswithtype2diabetes
AT okadayosuke associationsbetweencontinuousglucosemonitoringderivedmetricsanddiabeticretinopathyandalbuminuriainpatientswithtype2diabetes
AT yoshiihidenori associationsbetweencontinuousglucosemonitoringderivedmetricsanddiabeticretinopathyandalbuminuriainpatientswithtype2diabetes
AT osonoitakeshi associationsbetweencontinuousglucosemonitoringderivedmetricsanddiabeticretinopathyandalbuminuriainpatientswithtype2diabetes
AT nishidakeiko associationsbetweencontinuousglucosemonitoringderivedmetricsanddiabeticretinopathyandalbuminuriainpatientswithtype2diabetes
AT shiraiwatoshihiko associationsbetweencontinuousglucosemonitoringderivedmetricsanddiabeticretinopathyandalbuminuriainpatientswithtype2diabetes
AT torimotokeiichi associationsbetweencontinuousglucosemonitoringderivedmetricsanddiabeticretinopathyandalbuminuriainpatientswithtype2diabetes
AT kurozumiakira associationsbetweencontinuousglucosemonitoringderivedmetricsanddiabeticretinopathyandalbuminuriainpatientswithtype2diabetes
AT goshomasahiko associationsbetweencontinuousglucosemonitoringderivedmetricsanddiabeticretinopathyandalbuminuriainpatientswithtype2diabetes
AT shimomuraiichiro associationsbetweencontinuousglucosemonitoringderivedmetricsanddiabeticretinopathyandalbuminuriainpatientswithtype2diabetes
AT watadahirotaka associationsbetweencontinuousglucosemonitoringderivedmetricsanddiabeticretinopathyandalbuminuriainpatientswithtype2diabetes